In Case You Missed It: The Week's Top Infectious Disease Stories

A new monoclonal antibody, invasive group A strep, and genital herpes topped the list of this week's most-read stories.

A new monoclonal antibody, invasive group A strep, and genital herpes topped the list of this week's most-read stories.

1. Bivalent Booster Provides Protection Against Severe COVID-19, Possible Hospitalization

In a new CDC report, these immunizations aid against emergency department and urgent care encounters in immunocompetent adults.

2. Invasive Strep A Cases Increase in the US, Internationally

The Centers for Disease Control and Prevention (CDC) is looking into the possibility of this rare group of infections emerging.

3. Economic Impact of Genital Herpes Indicates Developing a Vaccine Should Be Top Priority

Genital herpes (HSV-2) affects quality-of-life but also causes substantial economic losses, especially in low- and middle-income countries.

4. Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy

Virax Biolabs has developed a T-cell testing platform to develop an immune risk profile against viral threats.

5. FDA Approves Monoclonal for COVID-19 Treatment in Hospitalized Adults

Roche’s Actemra is the first FDA approved monoclonal antibody to be used for COVID-19.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.